Khoo et al 2021 (resonance) ¿ ¿single-centre experience with three metallic ureteric stents (allium® urs, memokath¿-051 and resonance®) for chronic ureteric obstruction¿.Operating theatre records were reviewed to identify patients who had undergone metallic ureteric stent insertion with either allium® urs, memokath¿-051 or resonance® for cuo.Post-operatively, all patients were reviewed in clinic with serum creatinine, abdominal x-ray, and mercaptoacetyltriglycine-3 (mag-3) renogram at 6 weeks, and reviewed again with serum creatinine and abdominal x-ray at 3 months and then every 6 months.If there was clinical concern of stent failure, ct urogram (if estimated glomerular filtration rate (egfr) =30ml/min/1.73m2) or urinary tract ultrasound (if egfr <30ml/min/1.73m2) was performed.At each follow-up appointment, patient-reported stent symptoms (including irritative voiding symptoms, pain, and haematuria) were noted.Resonance: 29 patients, 58 sies) 6 cases of obstruction reported.(as per figure 5a 10% of 58 sie's = approx.6 devices).As per clinical input: require intervention/additional procedures to prevent permanent impairment/damage.
|
Device evaluation: the unknown devices of unknown lot number involved in this complaint were not available for evaluation.With the information provided, a document based investigation was conducted.Document review: as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution rms devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.It should be noted that the instructions for use (ifu0020-18) lists diminished urine drainage/ stent occlusion as a known potential adverse event associated with rms procedures.Root cause review: a definitive root cause could not be determined as the circumstances of use cannot be replicated in the laboratory.A possible root cause could be attributed to patient pre-existing conditions.As per the ifu, diminished urine drainage/ stent occlusion is listed as a known potential adverse event associated with rms procedures.Summary: the complaint is confirmed based on customer testimony.As per clinical input the patients would have required intervention/additional procedures to prevent permanent impairment/damage.Complaints of this nature will continue to be monitored for potential emerging trends.
|